Correction to: Scientific Reports https://doi.org/10.1038/s41598-019-40114-7, published online 11 March 2019
The Acknowledgements section in this Article is incomplete.
“The authors would like to thank Mrs Reyes Molina from the animal facility service at the Andalusian Centre for Nanomedicine & Biotechnology (BIONAND), Malaga, Spain. Mrs Ana Molina for the immunological analysis in IBIMA laboratories, Malaga, Spain and David Andreu from the Department of Experimental and Health Sciences, Universitat Pompeu Fabra of Barcelona for the synthesis of Prup3 T-cell peptide. The study was funded by the Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness: PI12/02481, PI15/00559 and PI18/00288, RETICS ARADyAL (RD16/0006/0001, /0003, /0011) and Sara Borrell Program (CD14/00242). Andalusian Regional Ministry of Economy and Knowledge: CTS-7433), Nicolas Monardes Program (C-0044-2012 SAS2013) and the Spanish Ministry of Economy and Competitiveness (CTQ2014-52328-P, CTQ2017-86265-P and AGL2014-52395-C2-2) and a FPI grant (JRS). Grants were cofunded by the European Regional Development Fund (ERDF).”
should read:
“The authors would like to thank Mrs Reyes Molina from the animal facility service at the Andalusian Centre for Nanomedicine & Biotechnology (BIONAND), Malaga, Spain. Mrs Ana Molina for the immunological analysis in IBIMA laboratories, Malaga, Spain and David Andreu from the Department of Experimental and Health Sciences, Universitat Pompeu Fabra of Barcelona for the synthesis of Prup3 T-cell peptide. The study was funded by the Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness co-founded by Fondo Europeo de Desarrollo Regional for the Thematic Networks and Co-operative Research Centres Una manera de hacer Europa: PI12/02481, PI15/00559 and PI18/00288, RETICS ARADyAL (RD16/0006/0001, /0003, /0011) and Sara Borrell Program (CD14/00242). Andalusian Regional Ministry of Health, Nicolas Monardes Program (C-0044- 2012 SAS2013). Andalusian Regional Ministry of Economy and Knowledge: CTS-7433), and the Spanish Ministry of Economy and Competitiveness (CTQ2014-52328-P, CTQ2017-86265-P and AGL2014-52395-C2-2) and a FPI grant (JRS). Grants were cofunded by the European Regional Development Fund (ERDF).”
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rodriguez, M.J., Ramos-Soriano, J., Perkins, J.R. et al. Author Correction: Glycosylated nanostructures in sublingual immunotherapy induce long-lasting tolerance in LTP allergy mouse model. Sci Rep 10, 6858 (2020). https://doi.org/10.1038/s41598-020-63855-2
Published:
DOI: https://doi.org/10.1038/s41598-020-63855-2
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
